EUVIMEDEUVIMED entdecken
Open Access

Glioma genetic profiles associated with electrophysiologic hyperexcitability

Steven Tobochnik iD, Maria Kristina C Dorotan, Hia S Ghosh, Emily Lapinskas, Jayne Vogelzang, David A Reardon, Keith L Ligon, Wenya Linda Bi, Stelios M Smirnakis, Jong Woo Lee

Neuro-Oncology · 02.02.2024 · 26 (2) · 323-334

DOI: 10.1093/neuonc/noad176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 15.09.2023. Verfasst von Steven Tobochnik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, VA Boston Healthcare System, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Epilepsy. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, VA, Department of Veterans Affairs, Veterans Health Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Distinct genetic alterations determine glioma aggressiveness, however, the diversity of somatic mutations contributing to peritumoral hyperexcitability and seizures over the course of the disease is uncertain. This study aimed to identify tumor somatic mutation profiles associated with clinically significant hyperexcitability.

Methods

A single center cohort of adults with WHO grades 1–4 glioma and targeted exome sequencing (n = 1716) was analyzed and cross-referenced with a validated EEG database to identify the subset of individuals who underwent continuous EEG monitoring (n = 206). Hyperexcitability was defined by the presence of lateralized periodic discharges and/or electrographic seizures. Cross-validated discriminant analysis models trained exclusively on recurrent somatic mutations were used to identify variants associated with hyperexcitability.

Results

The distribution of WHO grades and tumor mutational burdens were similar between patients with and without hyperexcitability. Discriminant analysis models classified the presence or absence of EEG hyperexcitability with an overall accuracy of 70.9%, regardless of IDH1 R132H inclusion. Predictive variants included nonsense mutations in ATRX and TP53, indel mutations in RBBP8 and CREBBP, and nonsynonymous missense mutations with predicted damaging consequences in EGFR, KRAS, PIK3CA, TP53, and USP28. This profile improved estimates of hyperexcitability in a multivariate analysis controlling for age, sex, tumor location, integrated pathologic diagnosis, recurrence status, and preoperative epilepsy. Predicted somatic mutation variants were over-represented in patients with hyperexcitability compared to individuals without hyperexcitability and those who did not undergo continuous EEG.

Conclusion

These findings implicate diverse glioma somatic mutations in cancer genes associated with peritumoral hyperexcitability. Tumor genetic profiling may facilitate glioma-related epilepsy prognostication and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaEpilepsyAdultHumansGenetic ProfileMutationSeizuresUbiquitin Thiolesterase

Stichwörter der Autor:innen

brain tumorelectroencephalographyepilepsygliomasomatic mutation

Substanzen

USP28 protein, humanUbiquitin Thiolesterase

Autor:innen und Institutionen

  • Department of Neurology, VA Boston Healthcare System, Boston, Massachusetts, USA.
  • Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Medical Oncology, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Steven Tobochnik

Förderung

  • NINDS NIH HHS
  • VA
  • Department of Veterans Affairs, Veterans Health Administration
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Tobochnik, S., Dorotan, M. K. C., Ghosh, H. S., Lapinskas, E., Vogelzang, J., Reardon, D. A., Ligon, K. L., Bi, W. L., Smirnakis, S. M., & Lee, J. W. (2024). Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-Oncology, 26(2), 323-334. https://doi.org/10.1093/neuonc/noad176

Vancouver

Tobochnik S, Dorotan MKC, Ghosh HS, Lapinskas E, Vogelzang J, Reardon DA, et al. Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro-Oncology. 2024;26(2):323-334. doi:10.1093/neuonc/noad176

BibTeX
@article{Tobochnik2024,
  author = {Tobochnik, Steven and Dorotan, Maria Kristina C and Ghosh, Hia S and Lapinskas, Emily and Vogelzang, Jayne and Reardon, David A and Ligon, Keith L and Bi, Wenya Linda and Smirnakis, Stelios M and Lee, Jong Woo},
  title = {Glioma genetic profiles associated with electrophysiologic hyperexcitability},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {2},
  pages = {323--334},
  doi = {10.1093/neuonc/noad176}
}
Kostenlos starten →